Revenues (Revenues Disaggregated by Significant Customer) (Details) - Sales revenue, net - Customer concentration risk |
12 Months Ended | ||
---|---|---|---|
Jan. 01, 2021 |
Jan. 03, 2020 |
Dec. 28, 2018 |
|
Ipsen | |||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||
Percent of total | 15.00% | 16.00% | 21.00% |
Affiliates of CVS Health Corporation | |||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||
Percent of total | 14.00% | 15.00% | 13.00% |
Affiliates of McKesson Corporation | |||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||
Percent of total | 12.00% | 12.00% | 12.00% |
Affiliates of Optum Specialty Pharmacy | |||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||
Percent of total | 11.00% | 13.00% | 14.00% |
Affiliates of AmerisourceBergen Corporation | |||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||
Percent of total | 11.00% | 11.00% | 9.00% |